Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ June 10, 2023 ] Graduating senior lights the path for transfer students – through her award-winning research and mentoring Los Angeles Biotech News
  • [ June 10, 2023 ] Postdoctoral Scientist – Karsh Division of Gastroenterology and Hepatology – Part-Time – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more Los Angeles Biotech News
  • [ June 10, 2023 ] Scientist, Cell Biology – Thermo Fisher Scientific – West Hills, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Security Officer – Biotechnology Company – Allied Universal® – Oceanside, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsDermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

August 26, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Reports Positive Phase 3 Results for Tapinarof Cream in Adult Patients with Plaque Psoriasis

Click to view original post

Previous

ChromaDex to Present at the LD 500 Virtual Investor Conference

Next

A Forbion-funded startup bought the rights to Amgen’s CETP inhibitor, and is giving the cholesterol drug another go

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered